Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1

Protein and Peptide Letters

Volumn 17, Issue 5, 2010, Pages 547-554

  Li, Hui ^a   Peng, Shun Lin ^a   Cui, Yu ^c   Fu, Qiu Xia ^b   Zhou, Yong ^b   Wang, Quan Li ^b   Zhan, Lin Sheng ^b   Zhong, Sen ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c The 89 Hospital of Chinese PLA   (China)

Author keywords

Affinity; BIA core; HLA B2705; Killer cell immunoglobulin like receptor; Peptide; Prokaryotic expression; Purification; SPR

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B ANTIGEN; HYBRID PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1;

ARTICLE; CHEMISTRY; ESCHERICHIA COLI; GEL CHROMATOGRAPHY; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN FOLDING; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

BETA 2-MICROGLOBULIN; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HLA-B ANTIGENS; HUMANS; PROTEIN BINDING; PROTEIN FOLDING; RECEPTORS, KIR3DS1; RECOMBINANT FUSION PROTEINS; SURFACE PLASMON RESONANCE;

HUMAN IMMUNODEFICIENCY VIRUS; PROKARYOTA;

EID: 77951985555     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610791112657     Document Type: Article

References (30)

1. Trinchieri, G. Biology of natural killer cells. Adv. Immunol., 1989, 47, 187-376.
2. Biron, C.A.; Nguyen, K.B.; Pien, G.C.; Cousens, L.P.; Salazar-Mather, T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol., 1999, 17, 189-220.
3. Moretta, A.; Biassoni, R.; Bottino, C.; Moretta, L. Surface receptors delivering opposite signals regulate the function of human NK cells. Semin. Immunol., 2000, 12(2), 129-138.
4. Lanier, L.L. NK cell recognition. Annu Rev Immunol., 2005, 23, 225-274.
5. Lanier, L.L. Turning on natural killer cells. J. Exp. Med., 2000, 191(8), 1259-1262.
6. Lanier, L.L.; Corliss, B.C.; Wu, J.; Leong, C.; Phillips, J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature, 1998, 391(6668), 703-707.
7. Wagtmann, N.; Biassoni, R.; Cantoni, C.; Verdiani, S.; Malnati, M.S.; Vitale, M.; Bottino, C.; Moretta, L.; Moretta, A.; Long, E.O. Molecular clones of the p58 NK cell receptor reveal immunoglobu-linrelated molecules with diversity in both the extra- and intracellular domains. Immunity, 1995, 2(5), 439-449.
8. Colonna, M.; Samaridis, J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science, 1995, 268(5209), 405-408.
9. Rajagopalan, S.; Long, E.O. Understanding how combinations of HLA and KIR genes influence disease. J. Exp Med., 2005, 201(7), 1025-1029.
10. Vilches, C.; Parham, P. title typecontributorKIR, diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol., 2002, 20, 217-251.
11. Long, E. O.; Rajagopalan, S. HLA class I recognition by killer cell Ig-like receptors. Semin. Immunol., 2000, 12(2), 101-108.
12. Hansasuta, P.; Dong, T.; Thananchai, H.; Weekes, M.; Willberg, C.; Aldemir, H.; Rowland-Jones, S.; Braud, V.M. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol., 2004, 34(6), 1673-1679.
13. Olcese, L.; Cambiaggi, A.; Semenzato, G.; Bottino, C.; Moretta, A.; Vivier, E. Human killer cell activatory receptors for MHC class molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol., 1997, 158, 5083-5086.
14. Long, E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol., 1999, 17, 875-904.
15. Stewart-Jones, G.B.; di Gleria, K.; Kollnberger, S.; McMichael, A.J.; Jones, E.Y.; Bowness, P. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B2705. Eur. J. Immunol., 2005, 35, 341-351.
16. Valés-Gómez, M.; Reyburn, H.T.; Mandelboim, M.; Strominger, J.L. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity, 1998, 9(3), 337-44.
17. Garboczi, D.N.; Utz, U.; Ghosh, P.; Seth, A.; Kim, J.; Van Tienhoven, E.A.; Biddison, W.E.; Wiley, D.C. Assembly, specific binding, and crystallization of a human TCR- alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J. Immunol., 1996, 157(12), 5403-10.
18. Garboczi, D.N.; Ghosh, P.; Utz, U.; Fan, Q.R.; Biddison, W.E.; Wiley, D.C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature, 1996, 384(6605), 134-41.
19. Garboczi, D.N.; Hung, D.T.; Wiley, D.C. HLA-A2-peptide complex, Refolding and crystallization of molecules expressed in E-scherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA, 1992, 89, 3429-3433.
20. Johnson, B.; Lofas, S.; Lindquist, G. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem., 1991, 198, 268-277.
21. Blassoni, R. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med., 1996, 183, 645-650.
22. Gumperz, J.E.; Litwin, V.; Phillips, J.H.; Lanie, L.L.; Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med., 1995, 181(3), 1133-1144.
23. Gillespie, G.M.; Bashirova, A.; Dong, D.W.; McVicar, D.W.; Rowland-Jones, S.L.; Carrington, M. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS. Res. Hum. Retroviruses., 2007, 23(3), 451-455.
24. Arnheim, L.; Dillner, J.; Sanjeevi, C.B. A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. Tissue Antigens, 2005, 65(3), 252-259.
25. Carrington, M.; Wang, S.; Martin, M.P.; Gao, X.; Schiffman, M.; Cheng, J.; Herrero, R.; Rodriguez, A.C.; Kurman, R.; Mortel, R.; Schwartz, P.; Glass, A.; Hildesheimm, A. Hierarchy of resistance to cervical neoplasia mediated by combination of killer immunoglobulin-like receptor and human leukocyte antigen loci. J. Exp. Med., 2005, 201(7), 1069-1075.
26. López-Vázquez, A.; Rodrigo, L.; Martínez-Borra, J.; Pérez, R.; Rodríguez, M.; Fdez-Morera, J.L.; Fuentes, D.; Rodríguez-Rodero, S.; Gonzáez, S.; López-Larrea, C. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-linke receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J. Infect. Dis., 2005, 192(1), 162-165.
27. Martin, M.P.; Gao, X.; Lee, J.H.; Nelson, G.W.; Detels, R.; Goedert, J.J.; Buchbinder, S.; Hoots, K.; Vlahov, D.; Trowsdale, J.; Wilson, M.; O'Brien, S.J.; Carrington, M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Gennet., 2002, 31(4),429-434.
28. Collins-Racie, L.A.; Colgan, Mc.; Grant, K.L.; DiBlasio-Smith, E.A.; McCoy, J.M.; LaVallie, E.R. Production of recombinant bovine enterokinase catalytic subunit in Escherichia coli using the novel secretory fusion partner DsbA. Biotechnology, 1995, 13(9), 982-987.
29. Winter, J.; Neubauer, R.; Glockshuber, R.; Rudolph, R. Increased production of human proinsulin in the periplasmic space of Escherichia coli fusion to DsbA. J. Biotechnol., 2000, 84(2), 175-185.
30. Altman, J.D.; Moss, P.A.; Goulder, P.J.; Barouch, D.H.; McHeyzer-Williams, M.G.; Bell, J.I.; McMichael, A.J.; Davis, M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science, 1996, 274(5284), 94-96.